A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure

Clinical trial NCT00001962 · TERMINATED

Trial details

NCT number: NCT00001962
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Aplastic Anemia Pure Red Cell Aplasia Diamond Blackfan Anemia

Start date: 1999-11-01
Primary completion: 2009-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.